Paper39476339
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis.
Bliddal H and 12 others. N Engl J Med, 2024. Cited by 322 papers, by iCite.
Cite this record
ConductScience Library. Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis. Papers, record 39476339. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39476339
- Disease
- obesity disorder354 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Randomized Controlled Trial, Multicenter Study, Clinical Trial, Phase III
- PubMed
Connected records2
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Obesity | Major topic |
| Osteoarthritis, Knee | Major topic |
| Weight Loss | Major topic |
| Glucagon-Like Peptide-1 Receptor Agonists | Major topic |
| Arthralgia | Major topic |
| Aged | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Body Mass Index | |
| Combined Modality Therapy | |
| Double-Blind Method | |
| Drug Administration Schedule | |
| Injections, Subcutaneous | |
| Counseling | |
| Caloric Restriction | |
| Pain Measurement | |
| Semaglutide |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Novo Nordisk | PubMed |
Source PubMed
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT05064735 | Research Study Looking at How Well Semaglutide Works in People Suffering From Obesity and Knee Osteoarthritis | Results | Yes | ClinicalTrials.gov |
| NCT07731256 | Semaglutide for Low Back Pain | Background | ClinicalTrials.gov |
Cited by236
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 322 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42978648 | Availability of age-stratified evidence for GLP1 receptor agonists and SGLT2 inhibitors: an analysis of European public assessment reports with a focus on older patients. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42978648 | PubMed |
| 42942810 | Retatrutide as a Unimolecular GIP/GLP-1/Glucagon Receptor Tri-Agonist: Molecular Design, Pharmaceutical Development and Critical Interpretation of Emerging Phase 3 Evidence. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42942810 | PubMed |
| 42942239 | Plant-Derived Polyphenols in Osteoarthritis: Mechanisms, Delivery Systems, and Therapeutic Synergy. | Life (Basel) | 2026 | https://conductscience.org/library/papers/42942239 | PubMed |
| 42941937 | Exploring Pathophysiological Processes Shared Between Type 2 Diabetes Mellitus and Osteoarthritis. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42941937 | PubMed |
| 42905201 | Dual GIP/GLP-1 receptor agonist versus selective GLP-1 receptor agonist in patients undergoing primary total knee or hip arthroplasty. | Eur J Orthop Surg Traumatol | 2026 | https://conductscience.org/library/papers/42905201 | PubMed |
| 42903858 | The emerging role of subchondral bone homeostasis in osteoarthritis. | J Orthop Translat | 2026 | https://conductscience.org/library/papers/42903858 | PubMed |
| 42893003 | Better osteoarthritis care requires prevention and stratification. | Mil Med Res | 2026 | https://conductscience.org/library/papers/42893003 | PubMed |
| 42892878 | Physical Activity Patterns in Adults Taking Glucagon-Like Peptide 1 Receptor Agonists: An All of Us Cross-sectional Study. | Diabetes Obes Cardiometab CARE | 2026 | https://conductscience.org/library/papers/42892878 | PubMed |
| 42889937 | Pharmacologic Treatment of Obesity in Adults: Standards of Care in Overweight and Obesity. | Diabetes Obes Cardiometab CARE | 2026 | https://conductscience.org/library/papers/42889937 | PubMed |
| 42884570 | GLP-1 Receptor Agonists, Gut Microbiota, and Chronic Pain: Nutritional Signaling at the Gut-Brain Axis. | Nutrients | 2026 | https://conductscience.org/library/papers/42884570 | PubMed |
| 42881169 | 15-PGDH inhibition in osteoarthritis: PGE2 skeletal interoception, cartilage regeneration and compartment-managed disease modification. | Bone Res | 2026 | https://conductscience.org/library/papers/42881169 | PubMed |
| 42875481 | Emerging therapies for knee osteoarthritis. | Nat Rev Rheumatol | 2026 | https://conductscience.org/library/papers/42875481 | PubMed |
| 42860897 | Glucagon-Like Peptide-1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review. | Ann Clin Transl Neurol | 2026 | https://conductscience.org/library/papers/42860897 | PubMed |
| 42851913 | Artificial intelligence in the biomechanics of knee osteoarthritis: biomechanical phenotyping, risk stratification, diagnosis, treatment and clinical translation-a narrative review. | Front Bioeng Biotechnol | 2026 | https://conductscience.org/library/papers/42851913 | PubMed |
| 42841007 | Non-surgical management of knee osteoarthritis: a stepped conservative care paradigm for early-stage disease and high-risk populations. | Front Surg | 2026 | https://conductscience.org/library/papers/42841007 | PubMed |
| 42825923 | Management of type 2 diabetes, 2026. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). | Diabetologia | 2026 | https://conductscience.org/library/papers/42825923 | PubMed |
| 42778434 | What does the gut microbiome teach us about osteoarthritis development and progression? | Best Pract Res Clin Rheumatol | 2026 | https://conductscience.org/library/papers/42778434 | PubMed |
| 42774139 | The incretin-joint axis: weight-independent mechanisms and disease-modifying potential in chronic arthropathies. | Rheumatol Adv Pract | 2026 | https://conductscience.org/library/papers/42774139 | PubMed |
| 42772870 | Systematic review of cost-effectiveness analyses of weight loss interventions for knee osteoarthritis. | BMJ Open | 2026 | https://conductscience.org/library/papers/42772870 | PubMed |
| 42772706 | Impact of an early body mass index maintenance intervention at ART initiation on diabetes risk: Insights from a computer simulation study. | Ann Epidemiol | 2026 | https://conductscience.org/library/papers/42772706 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| GLP1R | 2740 | PubTator's text mining | https://conductscience.org/library/genes/2740 |
Source NCBI Gene
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| SEMAGLUTIDE | CHEMBL2108724 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL2108724 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- References
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39476339
GET https://conductscience.org/api/papers/v1/39476339/cited_by?page=2